Genetic Insights into the Economic Toll of Cell Line Misidentification: A Comprehensive Review

Probably not a substantial claim: may not pass S3 (load-bearing).

dPCR requires low DNA quantities.

“It requires low DNA quantities and provides exquisite sensitivity for absolute quantification of target nucleic acids [54,55,56].”

• cites [54] Quan, P.L., Sauzade, M., and Brouzes, E. (2018). dPCR: A technology review. Sensors, 18. sourceDisputed

  Section 1.2 says dPCR partitions a sample so that each partition contains few or no target sequences; it does not say the sample must contain little DNA. Section 3.2 describes detection at high molecule concentrations and says the number of target sequences detected can exceed the number of partitions. Low DNA quantity is therefore not a requirement stated by this source. (LLM, conf=0.82)

  Checked by a reasoning model — may be wrong.

  Experimental — accuracy not yet measured
• cites [55] Trouchet, 2025, Digital PCR: From early developments to its future application in clinics, Lab Chip sourceSupported
• cites [56] Aujean, 2020, Genomic DNA PCR analysis to assess xenograft development in mouse mammary gland, Biotechniques sourceSupported

May combine two claims.

A single misidentified line MDA-MB-435 (long thought to be breast cancer but genetically indistinguishable from the melanoma line M14) spawned more than 1200 publications between 1982 and 2016, many of which were used in pre-clinical research.

“A single misidentified line such as MDA-MB-435 (long thought to be breast cancer but genetically indistinguishable from the melanoma line M14), spawned more than 1200 publications between 1982 and 2016, many of which were used in pre-clinical research [14].”

• cites [14] Korch, 2018, Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line, Int. J. Cancer sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Expert review remains crucial for STR profile interpretation despite software solutions.

“While software solutions like GeneMapper® ID-X [41], STRait Razor [42], and the open-source Haplotype inference and phasing for STRs (HipSTR) [43] include peak-height ratios, heterozygosity thresholds, and ladder alignment checks to minimize false calls, expert review remains crucial [44].”

• cites [44] Han, 2025, Next-generation sequencing-based tools or nanopore-based tools: Which is more suitable for short tandem repeats genotyping of nanopore sequencing?, Bioinform. Adv. sourceCould not verify

  The Results (§3.3 and §3.5; page unavailable) document STR genotyping errors and limitations of software tools. The Conclusion (§4; page unavailable) calls for future algorithm optimization, but neither it nor the passages retrieved for manual or expert review says that expert review of STR profiles remains crucial. (LLM, conf=0.76)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Curated reference databases such as ATCC STR, DSMZ's Cell Line Portal, and CLASTR at Cellosaurus were created as a technological advancement for STR profiling.

“The third, and perhaps most significant, advancement was the creation of curated reference databases such as ATCC STR [34], DSMZ’s Cell Line Portal [35], and CLASTR at Cellosaurus [36,37].”

• cites [34] ATCC (2025, November 23). Search the STR Database. Available online: https://www.atcc.org/search-str-database.Not checked yet

  Not checked in the free run.

• cites [35] Koblitz, 2022, DSMZCellDive: Diving into high-throughput cell line data, F1000Research sourceSupported
• cites [36] Robin, 2020, CLASTR: The Cellosaurus STR similarity search tool—A precious help for cell line authentication, Int. J. Cancer sourceSupported
• cites [37] Bairoch, 2018, The Cellosaurus, a cell-line knowledge resource, J. Biomol. Tech. sourcePartly supported

  The “STR profile sites” section says Cellosaurus incorporated reference STR profiles for cell-line authentication and identifies ATCC and DSMZ as sites offering profile searches. Our copy does not identify a tool called CLASTR at Cellosaurus, so it supports the database context but not that specific identification. No page number is available in the indexed passages. (LLM, conf=0.82)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

The redundancy among sex markers helps address Amelogenin dropout caused by Y-chromosome deletions in certain leukemias and other tumor cells.

“The redundancy among sex markers helps to address the rare but documented issue of Amelogenin dropout, which can be caused by Y-chromosome deletions in certain leukemias and other tumor cells [40].”

• cites [40] Chen, 2025, Concurrent loss of the Y chromosome in cancer and T cells impacts outcome, Nature sourcePartly supported

  The 'Tumour LOY and cohort characteristics' section examines Y-chromosome loss across cancers and includes acute myeloid leukemia among the cancer types studied (page unavailable). The paper does not establish that this loss causes Amelogenin dropout or that redundant sex markers address it. (LLM, conf=0.82)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

The NIST Short Tandem Repeat DNA database provides in-depth information about STRs and other identification markers used in human identification testing.

“Additionally, the recently updated Short Tandem Repeat DNA database hosted by the National Institute of Standards and Technology (NIST) provides in-depth information about STRs and other identification markers used in human identification testing [38,39].”

• cites [38] Ruitberg, 2001, STRBase: A short tandem repeat DNA database for the human identity testing community, Nucleic Acids Res. sourceSupported
• cites [39] (2025, November 23). Short Tandem Repeat DNA Database (Version 2.0), Available online: https://strbase.nist.gov/.Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

Software solutions like GeneMapper ID-X, STRait Razor, and HipSTR include peak-height ratios, heterozygosity thresholds, and ladder alignment checks to minimize false calls.

“While software solutions like GeneMapper® ID-X [41], STRait Razor [42], and the open-source Haplotype inference and phasing for STRs (HipSTR) [43] include peak-height ratios, heterozygosity thresholds, and ladder alignment checks to minimize false calls, expert review remains crucial [44].”

• cites [41] Soldati, 2025, Validation of the investigator argus y-28 qs kit on the seqstudio™ genetic analyzer for hid: A new panel file for genemapper id-x software v1.6, Int. J. Leg. Med. sourceNot checked — no full text of the source
• cites [42] Warshauer, 2015, STRait Razor v2.0: The improved STR Allele Identification Tool--Razor, Forensic Sci. Int. Genet. sourceNot checked — no full text of the source
• cites [43] Willems, 2017, Genome-wide profiling of heritable and de novo STR variations, Nat. Methods sourcePartly supported

  The Main Text identifies HipSTR as an STR-calling tool, supporting the citation’s identification of it. Online Methods (The HipSTR algorithm; Experiments) describe stutter modeling and a spanning-read support ratio used to filter de novo mutation calls, but do not establish that HipSTR includes peak-height ratios, heterozygosity thresholds, or ladder alignment checks. No page numbers are available in our copy. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Capillary electrophoresis with six-dye detection improved resolution of overlapping size ranges and decreased spectral bleed-through.

“The second advancement was the introduction of capillary electrophoresis with six-dye detection, which improved the resolution of overlapping size ranges and decreased spectral bleed-through [33].”

• cites [33] Durney, 2015, Capillary electrophoresis applied to DNA: Determining and harnessing sequence and structure to advance bioanalyses (2009–2014), Anal. Bioanal. Chem. sourcePartly supported

  The DNA sizing section (page unavailable) says that fluorescent labels distinguish STR fragments whose lengths overlap, resolving them spectrally. It describes four dyes, not six, and does not report decreased spectral bleed-through. Searches for six-dye detection and bleed-through found no supporting passage. (LLM, conf=0.88)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

In 2024, non-verifiable cell lines could lead to the creation of new cell lines without published description of how cell lines were established, STR profile, or making cell lines available through external suppliers, a phenomenon known as "miscelling".

“An update in 2024 discussed how non-verifiable cell lines could lead to the creation of new cell lines without published description of how cell lines were established, STR profile, or making cell lines available through external suppliers, a phenomenon known as “miscelling” [20].”

• cites [20] Oste, 2024, Misspellings or “miscellings”-Non-verifiable and unknown cell lines in cancer research publications, Int. J. Cancer sourceSupported

May combine two claims.

When scientists use misidentified cell lines, unreliable and irreproducible results will be established, leading to increased costs and misguided future studies.

“It is obvious that when scientists use misidentified cell lines, unreliable and irreproducible results will be established, leading to increased costs and misguided future studies [28].”

• cites [28] Weiskirchen, S., Schröder, S.K., Buhl, E.M., and Weiskirchen, R. (2023). A beginner’s guide to cell culture: Practical advice for preventing needless problems. Cells, 12. sourcePartly supported

  The Introduction and §5.5 (page not available in our copy) link cell-line misidentification to false, irreproducible results and misleading papers. The paper does not state that this increases costs or specifically leads to misguided future studies. (LLM, conf=0.85)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Murine hybridoma libraries provide monoclonal antibodies.

“Murine hybridoma libraries provide monoclonal antibodies, insect cells power baculovirus expression systems, and plant protoplasts allow for CRISPR screens in agriculture [71,72,73].”

• cites [71] Listek, 2020, A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line, Sci. Rep. sourceSupported
• cites [72] Yuan, J., Chen, J., Zhao, Q., Xu, J., Li, X., Zhang, Y., Li, H., Chen, X., Zhao, L., and Zhang, X. (2025). Advancements in the application and research of baculovirus vector vaccines for respiratory diseases in human. Front. Microbiol., 16. sourceCould not verify

  The Introduction section on baculovirus expression vector systems describes insect cells producing recombinant proteins, which supports a different clause of the citing sentence. The MERS preclinical investigations section discusses antibodies in vaccinated mice, but neither it nor passages retrieved for “murine hybridoma libraries” and “hybridoma monoclonal antibody production” addresses the quoted claim. (LLM, conf=0.75)

  Experimental — accuracy not yet measured
• cites [73] Creeth, R., Thompson, A., and Kevei, Z. (2025). DNA-free CRISPR genome editing in raspberry (Rubus idaeus) protoplast through RNP-mediated transfection. Front. Genome Ed., 7. sourceSupported

May combine two claims.

A meaningful STR test including the electrophoretic profile typically costs around $100-200, while consumable costs are about $40 for baseline STR genotyping.

“currently, companies provide a meaningful STR test, including the electrophoretic profile, typically costing around $100–200, while the consumable costs are about $40 for base line STR genotyping [15,138,139].”

• cites [15] Freedman, L.P., Cockburn, I.M., and Simcoe, T.S. (2015). The economics of reproducibility in preclinical research. PLoS Biol., 13, Erratum in: PLoS Biol. 2018, 16, e1002626. sourceNot checked — no full text of the source
• cites [138] Navarro-Bailón, A., Carbonell, D., Escudero, A., Chicano, M., Muñiz, P., Suárez-González, J., Bailén, R., Oarbeascoa, G., Kwon, M., and Díez-Martin, J.L. (2020). Short tandem repeats (STRs) as biomarkers for the quantitative follow-up of chimerism after stem cell transplantation: Methodological considerations and clinical application. Genes, 11. sourcePartly supported

  Section 4.1 reports that STR-PCR requires capillary electrophoresis and costs about €35 per post-transplant follow-up sample. It does not report a $100–200 commercial test price or $40 in consumables for baseline genotyping; instead, it estimates pretransplant screening at about €70 per donor–recipient pair. No page number is available in our copy. (LLM, conf=0.84)

  Experimental — accuracy not yet measured
• cites [139] Labcorp (2025, November 23). Available online: https://celllineauthentication.labcorp.com/pricing.Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

There was an infamous patent dispute over the BRCA1 and BRCA2 genes.

“A good example is the infamous patent dispute over the BRCA1 and BRCA2 genes [147,148].”

• cites [147] Matthijs, 2004, Patenting genes, BMJ sourceSupported
• cites [148] Matthijs, 2006, The European opposition against the BRCA gene patents, Fam. Cancer sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

Low-pass whole-genome sequencing (lpWGS) costs less than €150 per sample.

“Low-pass whole-genome sequencing (lpWGS) has recently reached the significant milestone of costing less than €150 per sample [51].”

• cites [51] Mazzonetto, 2024, Low-pass whole genome sequencing is a reliable and cost-effective approach for copy number variant analysis in the clinical setting, Ann. Hum. Genet. sourcePartly supported

  The Discussion (page unavailable) says LP-WGS costs approximately 50% less than microarray testing and that multiplexing reduces sequencing cost per patient. It does not give a price in euros or establish that the cost is below €150 per sample; its mention of 150 refers to the number of samples a flow cell can run. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Methylation barcodes and epigenetic clocks represent the latest advancements in the field.

“Methylation barcodes and epigenetic clocks represent the latest advancements in the field [58,59,60].”

• cites [58] Tian, 2023, Single-cell DNA methylation and 3D genome architecture in the human brain, Science sourcePartly supported

  The section on single-cell methylation barcodes describes scMCodes developed to identify human brain cell types, supporting the barcode part of the claim. The Discussion mentions predicting epigenetic age, but does not identify epigenetic clocks as an advancement made or assessed by this paper, nor establish that both are the latest advancements. (LLM, conf=0.82)

  Experimental — accuracy not yet measured
• cites [59] Shibata, 2025, Human brain ancestral barcodes, Elife sourcePartly supported

  The Introduction (page unavailable) presents fluctuating CpG methylation as a dynamic barcode for studying human brain development, supporting the methylation-barcode part of the claim. The paper does not describe epigenetic clocks as a latest advancement; a methylation-clock study appears only in its References (page unavailable). (LLM, conf=0.82)

  Experimental — accuracy not yet measured
• cites [60] Fuentealba, 2025, A blood-based epigenetic clock for intrinsic capacity predicts mortality and is associated with clinical, immunological and lifestyle factors, Nat. Aging sourcePartly supported

  The Main section describes the development of a DNA methylation-based epigenetic clock, and Results > DNAm-based predictor of IC compares it with established clocks (page numbers not supplied). This supports the epigenetic-clock part of the sentence, but the paper does not discuss methylation barcodes or establish that both are the latest advancements in the field. (LLM, conf=0.83)

  Experimental — accuracy not yet measured

May combine two claims.

A fraction of STRs can act as regulators of genome function by modulating DNA methylation, which may impact molecular mechanisms affecting disease or altering drug-response pathways.

“This suggests that a fraction of STRs can act as regulators of genome function by modulating DNA methylation, which may impact molecular mechanisms affecting disease or altering drug-response pathways [61].”

• cites [61] Garg, 2023, Genome-wide evaluation of the effect of short tandem repeat variation on local DNA methylation, Genome Res. sourcePartly supported

  The Discussion (page not provided) states that a fraction of STRs regulate genome function by modulating DNA methylation in cis and may underlie phenotypic variation and disease. Our copy does not connect this finding to altered drug-response pathways, so that part of the claim is unsupported. (LLM, conf=0.88)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Wiley journals recently introduced guidelines to prevent publication of studies involving misidentified or cross-contaminated cells.

“journals within Wiley’s group have recently introduced guidelines to prevent the publication of studies involving misidentified or cross-contaminated cells [93].”

• cites [93] Weiskirchen, 2025, Cell line authentication and validation is a key requirement for Journal of Cell Communication and Signaling publications, J. Cell Commun. Signal. sourcePartly supported

  The paper’s Abstract describes updated cell-line authentication and contamination-testing requirements at the Journal of Cell Communication and Signaling, intended to reduce problematic studies in the published literature. It does not establish that multiple Wiley journals recently introduced such guidelines; it says JCCS’s requirements align with Wiley publishing ethics guidelines first published in 2006. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

May combine two claims.

MIACA and MIACARE checklists help standardize field names and establish controlled vocabularies for species, tissue of origin, culture medium, and STR kit version.

“The Minimum Information About a Cellular Assay (MIACA) and the Minimum Information About a Cellular Assay in Regenerative Medicine (MIACARE) checklists help to standardize field names (e.g., “passage_number” vs. “passageNo”) and establish controlled vocabularies for species, tissue of origin, culture medium, and STR kit version [113,114].”

• cites [113] Wiemann, S., Mehrle, A., Hahne, F., Hermjakob, H., Apweiler, R., Arlt, D., Bechtel, S., Bielke, W., Birmingham, A., and Smith, Q. (2025, November 23). MIACA—Minimum Information About a Cellular Assay, and the Cellular Assay Object Model. Available online: http://miaca.sourceforge.net.Not checked yet

  Not checked in the free run.

• cites [114] Sakurai, 2016, First proposal of minimum information about a cellular assay for regenerative medicine, Stem Cells Transl. Med. sourcePartly supported

  The Introduction and Materials and Methods (Ontology Assignment; page numbers unavailable) support the general point that these reporting guidelines standardize assay information and that controlled terms were assigned to the regenerative-medicine checklist. But the paper calls that checklist MIACARM, not MIACARE, and does not establish the claimed field-name example or controlled vocabularies for each listed field, including STR kit version. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

dPCR provides exquisite sensitivity for absolute quantification of target nucleic acids.

“It requires low DNA quantities and provides exquisite sensitivity for absolute quantification of target nucleic acids [54,55,56].”

• cites [54] Quan, P.L., Sauzade, M., and Brouzes, E. (2018). dPCR: A technology review. Sensors, 18. sourcePartly supported

  Section 1.2 states that dPCR enables absolute quantification of target nucleic acids. But Section 7 says dPCR has lower sensitivity for absolute quantification than qPCR, so the review does not support the unqualified description of its sensitivity as “exquisite.” (LLM, conf=0.88)

  Experimental — accuracy not yet measured
• cites [55] Trouchet, 2025, Digital PCR: From early developments to its future application in clinics, Lab Chip sourceSupported
• cites [56] Aujean, 2020, Genomic DNA PCR analysis to assess xenograft development in mouse mammary gland, Biotechniques sourcePartly supported

  The Abstract says digital droplet PCR requires low DNA quantities and reports its use to detect bovine DNA in xenografts. That supports the low-DNA portion of the citing sentence, but the passages do not establish exquisite sensitivity or absolute quantification of target nucleic acids. (LLM, conf=0.78)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

For mouse, MUGA can be combined with CLASP for cell line authentication and copy number analysis.

“For mouse there is a Mouse Universal Genotyping Array (MUGA) available that can be combined with a computational method called Cell Line Authentication by SNP Profiling (CLASP) for cell line authentication and copy number analysis [66].”

• cites [66] Didion, J.P., Buus, R.J., Naghashfar, Z., Threadgill, D.W., Morse, H.C., and de Villena, F.P. (2014). SNP array profiling of mouse cell lines identifies their strains of origin and reveals cross-contamination and widespread aneuploidy. BMC Genomics., 15. sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

SSR assays are suitable for verifying the purity of cultivars in Arabidopsis and maize.

“Plant researchers use simple sequence repeat (SSR) assays, which are suitable for verifying the purity of cultivars in Arabidopsis and maize [70].”

• cites [70] Sureshkumar, 2025, Simple sequence repeats and their expansions: Role in plant development, environmental response and adaptation, New Phytol. sourcePartly supported

  The “Repeats in plant genomes” section (page unavailable) says plant geneticists use microsatellites as markers for mapping and marker-assisted selection. It does not say that SSR assays verify cultivar purity in Arabidopsis or maize; searches for purity and cultivar identification did not find that application in our copy. (LLM, conf=0.85)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Plant cell suspensions like BY-2 frequently exhibit somaclonal variation, impacting secondary metabolite profiles and reducing productivity.

“In agricultural biotechnology, plant cell suspensions like the tobacco Bright Yellow-2 (BY-2) frequently exhibit somaclonal variation, impacting secondary metabolite profiles and reducing productivity [82].”

• cites [82] Häkkinen, S.T., Reuter, L., Nuorti, N., Joensuu, J.J., Rischer, H., and Ritala, A. (2018). Tobacco BY-2 Media component optimization for a cost-efficient recombinant protein production. Front. Plant Sci., 9. sourcePartly supported

  The Introduction (page unavailable) says plant cell cultures often exhibit somaclonal variation that can lead to loss of productivity or metabolic competence. It does not say that the variation changes secondary metabolite profiles, and the Discussion (page unavailable) reports stable recombinant-protein expression in the BY-2 cells studied rather than a productivity decline in those cells. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Xenome can perform fast, accurate and specific classification of sequence reads.

“like Xenome, which can perform fast, accurate and specific classification of sequence reads [80]”

• cites [80] Conway, 2012, Xenome—A tool for classifying reads from xenograft samples, Bioinformatics sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Tools like CONICSmat first infer large-scale copy-number states from the expression matrix and then overlay these states onto the corresponding UMAP/t-SNE plots.

“For example, tools like CONICSmat first infer large-scale copy-number states from the expression matrix and then overlay these states onto the corresponding UMAP/t-SNE plots.”

• cites [52] Cho, 2018, CONICS integrates scRNA-seq with DNA sequencing to map gene expression to tumor sub-clones, Bioinformatics sourcePartly supported

  Section 1 (Introduction) says CONICS identifies large-scale copy-number variants in scRNA-seq, and Section 2.1 identifies CONICSmat as a related package that can be used without DNA-sequencing data. Our copy does not say that CONICSmat overlays inferred states on UMAP or t-SNE plots, so that part of the attributed workflow is unsupported. (LLM, conf=0.83)

  Experimental — accuracy not yet measured
• cites [53] Kumar, 2022, Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer, Cancer Discov. sourcePartly supported

  The Methods section (CNV Analysis; page not available in our copy) says the authors used CONICSmat to call CNVs from a gene-expression matrix. The Methods also describes UMAP visualization separately, but does not say CONICSmat overlays the inferred copy-number states on UMAP or t-SNE plots. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Research and development costs for new drug developments are in the range of $161 million to $4.54 billion.

“It is estimated that the research and development costs for new drug developments are in the range of $161 million to $4.54 billion [143].”

• cites [143] Schlander, 2021, How much does it cost to research and develop a new drug? A systematic review and assessment, Pharmacoeconomics sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Species-specific or custom-designed STR and SNP arrays to identify different breeds are becoming more common.

“For non-human models, species-specific or custom-designed STR and SNP arrays to identify different breeds are becoming more common [62,63,64].”

• cites [62] Cui, W., Jin, X., Guo, Y., Chen, C., Zhang, W., Wang, Y., Lan, J., and Zhu, B. (2020). Development and validation of a novel five-dye short tandem repeat panel for forensic identification of 11 species. Front. Genet., 11. sourcePartly supported

  The Methods section describes a custom-designed, species-specific STR panel, and the Discussion says many panels for animal species identification have been developed. The paper identifies species, not breeds; it does not establish that SNP arrays for breed identification are becoming more common. The Discussion also says that only a few STR-based panels had been used for animal species identification. (LLM, conf=0.88)

  Experimental — accuracy not yet measured
• cites [63] Thavornkanlapachai, 2024, Species-specific SNP arrays for non-invasive genetic monitoring of a vulnerable bat, Sci. Rep. sourcePartly supported

  The Introduction says SNP markers are being used more widely in wildlife studies, and the Results (SNP selection) describe custom SNP panels for identifying individual bats. The paper discusses microsatellite (STR) markers, but does not establish that custom STR arrays are becoming more common or that either type of array is used to identify different breeds. Page numbers are not available in our copy. (LLM, conf=0.88)

  Experimental — accuracy not yet measured
• cites [64] Takahashi, 2023, Development and validation of novel SNP markers for the rapid identification of natural hybrids of the 11 closely related pufferfish species (Takifugu spp.) distributed in Japan, Aquac. Rep. sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

Insect cells power baculovirus expression systems.

“Murine hybridoma libraries provide monoclonal antibodies, insect cells power baculovirus expression systems, and plant protoplasts allow for CRISPR screens in agriculture [71,72,73].”

• cites [71] Listek, 2020, A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line, Sci. Rep. sourceSupported
• cites [72] Yuan, J., Chen, J., Zhao, Q., Xu, J., Li, X., Zhang, Y., Li, H., Chen, X., Zhao, L., and Zhang, X. (2025). Advancements in the application and research of baculovirus vector vaccines for respiratory diseases in human. Front. Microbiol., 16. sourceSupported
• cites [73] Creeth, R., Thompson, A., and Kevei, Z. (2025). DNA-free CRISPR genome editing in raspberry (Rubus idaeus) protoplast through RNP-mediated transfection. Front. Genome Ed., 7. sourceCould not verify

  The Introduction and Discussion address CRISPR editing in plant protoplasts, not insect-cell baculovirus expression systems. Searches for “insect cells baculovirus expression systems” and “baculovirus insect cell recombinant protein expression” found no passage addressing the attributed claim. (LLM, conf=0.75)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

China's National Medical Products Administration has updated and strengthened its Technical Guidelines for Biological Drug Development, including cell and gene therapy products, to align with Quality of Biotechnological Products standards.

“China’s National Medical Products Administration (NMPA) has updated and strengthened its “Technical Guidelines for Biological Drug Development”, including cell and gene therapy products to align with the Quality of Biotechnological Products standards [97].”

• cites [97] Tan, 2025, Current landscape of innovative drug development and regulatory support in China, Signal Transduct. Target. Ther. sourcePartly supported

  The Introduction and the section on regulatory measures describe NMPA regulatory modernization and adoption of ICH guidelines. The section on innovative-drug classification also reports revised registration classifications for biologics. Our copy does not say that NMPA updated the named “Technical Guidelines for Biological Drug Development,” that those guidelines include cell and gene therapy products, or that they were aligned with “Quality of Biotechnological Products” standards. (LLM, conf=0.84)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Plant protoplasts allow for CRISPR screens in agriculture.

“Murine hybridoma libraries provide monoclonal antibodies, insect cells power baculovirus expression systems, and plant protoplasts allow for CRISPR screens in agriculture [71,72,73].”

• cites [71] Listek, 2020, A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line, Sci. Rep. sourceCould not verify

  The Introduction and Conclusions discuss murine hybridomas and screening for antibody-producing cells, not plant protoplasts. A search of our copy for plant protoplasts, CRISPR screens, and agricultural genome editing found no passage addressing the attributed claim. (LLM, conf=0.77)

  Experimental — accuracy not yet measured
• cites [72] Yuan, J., Chen, J., Zhao, Q., Xu, J., Li, X., Zhang, Y., Li, H., Chen, X., Zhao, L., and Zhang, X. (2025). Advancements in the application and research of baculovirus vector vaccines for respiratory diseases in human. Front. Microbiol., 16. sourceCould not verify

  The Introduction section on baculovirus expression vector systems describes protein production using insect cells, supporting a different clause of the citing sentence. Searches for plant protoplasts and agricultural CRISPR screens found no passage in our copy addressing the quoted claim. (LLM, conf=0.76)

  Experimental — accuracy not yet measured
• cites [73] Creeth, R., Thompson, A., and Kevei, Z. (2025). DNA-free CRISPR genome editing in raspberry (Rubus idaeus) protoplast through RNP-mediated transfection. Front. Genome Ed., 7. sourcePartly supported

  The Discussion reports CRISPR editing of three agriculturally relevant targets in raspberry protoplasts and says large-scale gRNA screening may be unavoidable. It does not report a CRISPR screen conducted in protoplasts, so it supports their potential for screening rather than an established screening application. (LLM, conf=0.79)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

In 2014, the FDA established the 'Emerging Technology Program' to evaluate innovative technologies, such as AI and ML.

“In 2014, the FDA established the ‘Emerging Technology Program’ to evaluate innovative technologies, such as AI and ML [159].”

• cites [159] Niazi, S.K. (2025). Regulatory perspectives for AI/ML implementation in pharmaceutical GMP environments. Pharmaceuticals, 18. sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

By using FRET probes, microfluidics or lab-on-a-chip can conduct assays in a short time, sending allele calls to central hubs or cloud-based dashboards.

“By using fluorescence resonance energy transfer (FRET) probes, microfluids or lab-on-a-chip can conduct assays in a short time, sending allele calls to central hubs or cloud-based dashboards [155].”

• cites [155] Verma, A.K., Noumani, A., Yadav, A.K., and Solanki, P.R. (2023). FRET based biosensor: Principle applications recent advances and challenges. Diagnostics, 13. sourcePartly supported

  Section 3.2 describes rapid point-of-need assays using microfluidic FRET biosensors. Section 4.2 says FRET biosensors could transmit data to a central hub or cloud-based platform, but it presents this as an IoT possibility, not as a demonstrated feature of the microfluidic assays. Neither passage says those assays produce or transmit allele calls. (LLM, conf=0.88)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

In one report, HRM technology was used to detect cross-adulteration of water buffalo, bovine, goat, sheep, camel, and donkey milks.

“In one report, this technology was used to detect cross-adulteration of water buffalo, bovine, goat, sheep, camel, and donkey milks [158].”

• cites [158] Bulut, 2023, High resolution melting is a useful tool to detect animal species sources of various milk types, J. Food Sci. Technol. sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Routine authentication through STR profiling requires the use of plastics, reagents, and energy, resulting in a carbon footprint.

“The process of routine authentication through STR profiling, like any other laboratory test, requires the use of plastics, reagents, and energy, resulting in a carbon footprint [149].”

• cites [149] Farley, M., and Nicolet, B.P. (2023). Re-use of laboratory utensils reduces CO2 equivalent footprint and running costs. PLoS ONE, 18. sourcePartly supported

  The Introduction (page unavailable) says laboratory research uses energy and materials and has a carbon footprint; the Abstract identifies single-use plastics as a major material. The paper assesses consumables used in cell and bacterial culture, not STR profiling, and does not establish the reagent requirements of routine STR authentication. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Initial trials using adaptive multi-scale autoencoders on single-cell RNA sequencing data have shown that self-supervised clustering methods are highly beneficial for downstream analysis, such as cell trajectory.

“Initial trials using adaptive multi-scale autoencoders on single-cell RNA sequencing data have shown that these self-supervised clustering methods are highly beneficial for downstream analysis, such as cell trajectory [157].”

• cites [157] Tan, 2024, scAMAC: Self-supervised clustering of scRNA-seq data based on adaptive multi-scale autoencoder, Brief. Bioinform. sourceSupported

May combine two claims.

H3Africa has shown that with proper logistics and funding, world-class genomic QC for producing high-quality biological samples is achievable in places like Nigeria and Zimbabwe, democratizing both participation and benefits.

“Initiatives like Human Heredity and Health in Africa (H3Africa) have shown that with proper logistics and funding, world-class genomic QC for producing high-quality biological samples is achievable in places like Nigeria and Zimbabwe, democratizing both participation and benefits [152,153].”

• cites [152] Matimba, 2016, Practical approach to biobanking in Zimbabwe: Establishment of an inclusive stakeholder framework, Biopreserv. Biobank. sourceNot checked — no full text of the source
• cites [153] Croxton, 2020, H3Africa partnerships to empower clinical research sites to generate high-quality biological samples, Afr. J. Lab. Med. sourcePartly supported

  The Methods and Results (Project B, Nigeria) describe standardized DNA quality criteria, training, shipping controls, and improved biospecimen quality at a Nigerian site. The paper does not demonstrate those results in Zimbabwe, which appears only in a reference, or establish that participation and benefits were democratized. It supports high-quality biospecimen production, but not the full geographic and societal claim. (LLM, conf=0.88)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

ML strategies are able to combine genomic and transcriptomic profiles to accurately predict tumor type, identify genetic abnormalities, and provide other clinically meaningful information in clinical routine.

“ML strategies are able to combine genomic and transcriptomic profiles to accurately predict tumor type, identify genetic abnormalities, and provide other clinically meaningful information in clinical routine [156].”

• cites [156] Abraham, 2021, Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type, Transl. Oncol. sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

Figure 4 displays a Hep 3B culture with an allele table that matches 100% with the published reference profile, meeting the ANSI/ATCC ≥90% criterion.

“Figure 4 displays a Hep 3B culture with an allele table that matches 100% with the published reference profile, meeting the ANSI/ATCC ≥ 90% criterion with certainty.”

Probably not a substantial claim: may not pass S4 (based).

Our modeling indicates that even a 5% hold-back on direct costs is sufficient to secure over 90% compliance within one funding cycle.

“Funding agencies, for their part, should continue tying disbursement schedules to demonstrable QC achievements; our modeling indicates that even a 5% hold-back on direct costs is sufficient to secure over 90% compliance within one funding cycle.”

May combine two claims.

Widespread use of misidentified cell lines not only compromises the credibility of individual studies, but can also result in significant harm, such as erroneous conclusions in clinical applications.

“The widespread use of misidentified cell lines not only compromises the credibility of individual studies, but can also result in significant harm, such as erroneous conclusions in clinical applications.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

A partial match is defined by 60-79% identity and requires further investigation, while anything lower is a mismatch requiring follow-up.

“A “partial match” between two samples is defined by an identity of 60–79% and requires further investigation, while anything lower is considered a “mismatch” that requires follow-up [32].”

• cites [32] (2022). Human Cell Line Authentication: Standardization of Short Tandem Repeat (STR) Profiling, ASN-0002-2021 (Standard No. ASN-0002-2021).Not checked yet

  Not checked in the free run.

May combine two claims.

The 2022 updated guidelines added five additional markers (D3S1358, D8S1179, D18S51, D21S11, FGA), increasing POI values to 1.14 × 10−15 and 2.97 × 10−15 for African American and Caucasian populations, respectively.

“The 2022 updated version of these guidelines added five additional markers (D3S1358, D8S1179, D18S51, D21S11, and FGA), increasing the POI values to 1.14 × 10−15 and 2.97 × 10−15, respectively [32].”

• cites [32] (2022). Human Cell Line Authentication: Standardization of Short Tandem Repeat (STR) Profiling, ASN-0002-2021 (Standard No. ASN-0002-2021).Not checked yet

  Not checked in the free run.

May combine two claims.

Cell line misidentification now compromises roughly one in five lines and renders thousands of papers potentially unreliable, propagating unreliable data through hundreds of thousands of citations.

“Cell line misidentification, first exposed when HeLa cells were shown to contaminate dozens of “unique” cultures, now compromises roughly one in five lines and renders thousands of papers potentially unreliable, propagating unreliable data through hundreds of thousands of citations.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

The ANSI/ATCC allele-concordance criteria and the Tanabe similarity coefficient are related but not equivalent and should not be confused.

“These thresholds are related but not equivalent and should not be confused.”

• AssumptionRests on an assumption: The Tanabe similarity score is often interpreted using ≥90% similarity for declaring same cell line in high-stringency applications.

Classified as probably not a substantial claim. May combine two claims.

The history of cell line misidentification teaches an unambiguous lesson: unchecked error perpetuates cost escalation, leading to a decline in public confidence.

“In short, the history of cell line misidentification teaches an unambiguous lesson: unchecked error perpetuates cost escalation, leading to a decline in public confidence.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Allele dropout can occur when DNA quantity falls below 100 pg or when high salt or detergent levels inhibit Taq polymerase.

“Allele dropout can occur when DNA quantity falls below 100 pg or when high salt or detergent levels inhibit Taq polymerase [32].”

• cites [32] (2022). Human Cell Line Authentication: Standardization of Short Tandem Repeat (STR) Profiling, ASN-0002-2021 (Standard No. ASN-0002-2021).Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

According to ANSI/ATCC ASN-0002-2022, a match requires ≥80% allele concordance across shared loci when 13 core STR loci are compared between two samples.

“According to ANSI/ATCC ASN-0002-2022 [32], a “match” requires ≥80% allele concordance across shared loci when 13 core STR loci are compared between two samples.”

• cites [32] (2022). Human Cell Line Authentication: Standardization of Short Tandem Repeat (STR) Profiling, ASN-0002-2021 (Standard No. ASN-0002-2021).Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

FAIR-compliant data archiving and integration of STR workflows into laboratory data management systems will allow laboratories to shift from sporadic testing of cell quality to continuous, artificial intelligence-supported assessments.

“It is further discussed that FAIR-compliant data archiving and integration of STR workflows into laboratory data management systems will allow laboratories to shift from sporadic testing of cell quality to continuous, artificial intelligence-supported assessments.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

ANSI/ATCC ASN-0002, the first formal cell-line authentication guideline, appeared in 2010 and was updated in 2022 after a two-year public comment period.

“The first formal guideline, ANSI/ATCC ASN-0002, appeared in 2010 and was updated in 2022 following a two-year public comment period [32].”

• cites [32] (2022). Human Cell Line Authentication: Standardization of Short Tandem Repeat (STR) Profiling, ASN-0002-2021 (Standard No. ASN-0002-2021).Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

ISO working groups are currently developing customized "fusion fingerprints" to document the expected heteroploid alleles.

“ISO working groups are currently developing customized “fusion fingerprints” to document the expected heteroploid alleles.”

Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

Each system presents unique authentication challenges that the scientific community is only just starting to comprehensively address.

“Each system presents unique authentication challenges that the scientific community is only just starting to comprehensively address.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Because SNPs are bi-allelic, downstream analysis can utilize simple binary matching algorithms, enabling high-throughput screening in core facilities.

“Because SNPs are bi-allelic, downstream analysis can utilize simple binary matching algorithms, enabling high-throughput screening in core facilities.”

• AssumptionRests on an assumption: SNPs are bi-allelic.

Probably not a substantial claim: may not pass S3 (load-bearing).

STR profiling is increasingly integrated with barcoding and Laboratory Information Management Systems (LIMS).

“Finally, STR profiling is increasingly integrated with barcoding and Laboratory Information Management Systems (LIMS) [48].”

• cites [48] Parker, 2012, Laboratory information management systems for DNA barcoding, Methods Mol. Biol. sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

Substrains like C57BL/6J and C57BL/6N diverged in 1951.

“Substrains like C57BL/6J and C57BL/6N, which diverged in 1951, and many other mouse strains commonly used in transgenic and knockout production have differences in metabolism, vision, immunopathology, and behavior [74].”

• cites [74] Bothe, 2004, Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice, Genes Brain Behav. sourceNot checked — no full text of the source

May combine two claims.

Species identification of cell lines and detection of cross-contamination can be done by targeting mitochondrial genomes.

“More general species identification of cell lines and detection of cross-contamination can also be done by targeting the mitochondrial genomes.”

Probably not a substantial claim: may not pass S3 (load-bearing).

A multiplex microsatellite marker panel containing 87 microsatellite markers can be used to authenticate rat strains with only 8 reactions.

“Similarly, a multiplex microsatellite marker panel containing 87 microsatellite markers can be used to authenticate rat strains with only 8 reactions [68].”

• cites [68] Bryda, 2008, Multiplex microsatellite marker panels for genetic monitoring of common rat strains, J. Am. Assoc. Lab. Anim. Sci.Not checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

GDPR classifies genetic data as a "special category", requiring explicit informed consent, data minimization, and the right to be forgotten.

“GDPR classifies genetic data as a “special category”, requiring explicit informed consent, data minimization, and the right to be forgotten [109].”

• cites [109] (2025, November 23). EU Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the Protection of Individuals with Regard to the Processing of Personal Data and on the Free Movement of Such Data. Available online: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31995L0046:en:HTML.Not checked yet

  Not checked in the free run.

May combine two claims.

dPCR outperforms electropherogram-based methods, which struggle to detect minor-allele contributions below 10%.

“This outperforms electropherogram-based methods, which struggle to detect minor-allele contributions below 10%.”

May combine two claims.

In pluripotent stem cell lines that undergo extensive CRISPR editing resulting in large chromosomal inversions, STR loci may still match the parental genotype while functional attributes and experimental validity could be compromised.

“For example, consider a pluripotent stem cell line that undergoes extensive CRISPR editing, resulting in large chromosomal inversions. While STR loci may still match the parental genotype, the functional attributes, and therefore the experimental validity, could be compromised.”

May combine two claims.

The 2022 revision of ANSI/ATCC ASN-0002 clarified match thresholds, added mycoplasma screening requirements, and mandated retention of raw electropherograms for at least five years.

“The revision clarified match thresholds, added requirements for mycoplasma screening, and mandated retention of raw electropherograms for a minimum of five years.”

• cites [32] (2022). Human Cell Line Authentication: Standardization of Short Tandem Repeat (STR) Profiling, ASN-0002-2021 (Standard No. ASN-0002-2021).Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

AACR journals have automated authentication: authors upload a PDF certificate during online submission, which is verified by an internal tool to confirm date, locus count, and match status.

“Journals from the American Association for Cancer Research (AACR) have automated the process: authors upload a PDF certificate during online submission, which is then verified by an internal tool to confirm the date, locus count, and match status [90].”

• cites [90] AACR Journals (2025, November 23). Available online: https://aacrjournals.org/pages/improv-reprod.Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

STR profiling has become the common language connecting local laboratory work to global repositories like ATCC, DSMZ, and Cellosaurus because the assay is affordable, rapid, and does not require specialized bioinformatics.

“Since the assay is affordable, rapid, and does not require specialized bioinformatics for interpretation, STR profiling has become the common language connecting local laboratory work to global repositories like ATCC, DSMZ, and Cellosaurus.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

FDA CMC information for human gene therapy INDs recommends identifying cells through tests that distinguish them from other cell lines used in the facility, and for purchased or received cell lines recommends MCB testing to confirm purity by genetic analysis such as STR or other profiling.

““You should identify your cells through tests that distinguish them from other cell lines used in your facility. For cell lines that you have purchased from a type collection, vendor, or received from another investigator, we recommend master cell bank (MCB) testing to confirm the purity of the cells by genetic analysis (i.e., short tandem repeat analysis or other profiling analysis)” [94].”

• cites [94] FDA Document (2025, November 23). Guidance for Industry. Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs), Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/chemistry-manufacturing-and-control-cmc-information-human-gene-therapy-investigational-new-drug.Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

STR profiling remains the undisputed standard in human cell authentication.

“While STR profiling remains the undisputed standard in human cell authentication, no single method can address every borderline case.”

Probably not a substantial claim: may not pass S3 (load-bearing).

Automation enhances reproducibility because when every step is scriptable, deviations can be traced and root-cause analysis becomes more effective.

“Finally, automation enhances reproducibility. When every step is scriptable, deviations can be traced and root-cause analysis becomes more effective.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

The Nature Publishing Group strongly encourages authentication and reserves the right to delay acceptance until certificates are submitted.

“The Nature Publishing Group “strongly encourages” authentication and reserves the right to delay acceptance until certificates are submitted [89].”

• cites [89] Nature Publishing Group (2025, November 23). Reporting Standards and Availability of Data, Materials, Code and Protocols. Available online: https://www.nature.com/natmachintell/editorial-policies/reporting-standards.Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

The Cellosaurus database, with systematically curated information and more than 9000 deposited STR profiles, currently represents the most reliable and comprehensive resource for accurate cell line identification.

“the Cellosaurus database, with its systematically curated information and more than 9000 deposited STR profiles, currently represents the most reliable and comprehensive resource for accurate cell line identification.”

May combine two claims.

Commercial SNP kits like Fluidigm's 96.96 Dynamic Array interrogate a few hundred ancestry-informative markers, providing information comparable to a 24-locus STR while reducing cost per data point.

“Commercial kits like Fluidigm’s 96.96 Dynamic Array interrogate a few hundred ancestry-informative markers, providing a level of information comparable to a 24-locus STR while reducing the cost per data point [50].”

• cites [50] Seeb, 2009, SNP genotyping by the 5’-nuclease reaction: Advances in high-throughput genotyping with nonmodel organisms, Methods Mol. Biol. sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

CellChain stores a hash of each STR profile on a public ledger, creating an immutable timestamp that proves the profile existed in a given state on a given date.

“Projects like CellChain store a hash of each STR profile on a public ledger, creating an immutable timestamp that proves the profile existed in a given state on a given date [122].”

• cites [122] CellChain (2025, November 23). Order CAR-T Cell Therapy Now with CellChain™. Available online: https://nl.cellcompass.com/providers/order#additional-information.Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

Fifteen years ago, several PCR-amplified sequences from selected loci were defined, capable of distinguishing among 40 uncharacterized nucleopolyhedrovirus isolates from larvae of the moth Spodoptera frugiperda.

“Fifteen years ago, several PCR-amplified sequences from selected loci were defined, capable of distinguishing among 40 uncharacterized nucleopolyhedrovirus isolates from larvae of the moth Spodoptera frugiperda (commonly known as the fall armyworm) [77].”

• cites [77] Rowley, 2010, Genetic and biological variation among nucleopolyhedrovirus isolates from the fall armyworm, Spodoptera frugiperda (Lepidoptera: Noctuidae), Virus Genes sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

Introducing such test systems must be critically validated under CLIA or ISO 17025 guidelines before becoming part of forensic assays.

“Moreover, introducing such test systems must be critically validated under these guidelines before becoming part of forensic assays [46].”

• cites [46] Buchard, 2016, ISO 17025 validation of a next-generation sequencing assay for relationship testing, Electrophoresis sourceNot checked — no full text of the source

May combine two claims.

Co-culturing human tumor organoids with mouse stromal cells improves physiological relevance but complicates downstream omics analysis.

“Co-culturing human tumor organoids with mouse stromal cells improve physiological relevance but complicates downstream omics analysis.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Laboratories seeking accreditation under CLIA or ISO 17025 must conduct positive and negative controls with every batch, document lot numbers, and participate in external proficiency testing.

“Laboratories seeking accreditation under CLIA or ISO 17025 [46] must conduct positive and negative controls with every batch, document lot numbers, and participate in external proficiency testing.”

• cites [46] Buchard, 2016, ISO 17025 validation of a next-generation sequencing assay for relationship testing, Electrophoresis sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

The 3200% 5-year ROI reported in Table 3 should be regarded as an illustrative scenario rather than a universal benchmark.

“The 3200% 5-year ROI reported in Table 3 should therefore be regarded as an illustrative scenario rather than a universal benchmark.”

Probably not a substantial claim: may not pass S3 (load-bearing).

FDA mandates explicit documentation of species composition in Investigational New Drug (IND) applications involving xenografts.

“Regulatory agencies such as the U.S. Food and Drug Administration (FDA) mandate explicit documentation of species composition in Investigational New Drug (IND) applications involving xenografts [81].”

• cites [81] U.S. Food & Drug Adminstration (2025, November 23). Guidance Document. Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans. Guidance for Industry, Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/source-animal-product-preclinical-and-clinical-issues-concerning-use-xenotransplantation-products.Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

A significant portion of basic and translational research relies on organisms other than humans.

“Human studies may dominate biomedical headlines, but a significant portion of basic and translational research relies on other organisms.”

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

At a mid-sized research university with around 400 active biomedical projects and centrally funded authentication, annual authentication costs could realistically reach about €1 million (€2500 per project).

“Estimating that a mid-sized research university manages around 400 active biomedical projects, and the institution centrally funds authentication, annual costs could realistically reach about €1 million (€2500 per project).”

• AssumptionThe authors state this as an assumption: A mid-sized research university manages around 400 active biomedical projects.
• AssumptionThe authors state this as an assumption: The institution centrally funds authentication.

Probably not a substantial claim: may not pass S3 (load-bearing).

According to U.S. patent law (35 U.S.C §101), "products of nature" cannot be patented.

“According to U.S. patent law (35 U.S.C §101), “products of nature” cannot be patented [146].”

• cites [146] (2025, November 23). 35 U.S.C. 101: Inventions Patentable. Available online: https://www.bitlaw.com/source/35usc/101.html.Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

Insect cell lines such as Sf9, High-FiveTM, and Drosophila S2 allow for high-yield production of recombinant proteins.

“Insect cell lines, such as Sf9, High-Five™, and Drosophila S2 allow for high-yield production of recombinant proteins, but they do not have the same extensive reference databases as mammalian systems.”

May combine two claims.

Applying human-centric standards to other organisms can result in false security and unnecessary expenses.

“Applying human-centric standards to other organisms can result in false security and unnecessary expenses.”

Probably not a substantial claim: may not pass S4 (based).

Policy evaluations demonstrate a growing global consensus, from ANSI/ATCC to FDA and EMA, that authentication has transitioned from being a best-practice to a mandatory requirement.

“Policy evaluations demonstrate a growing global consensus, from ANSI/ATCC to FDA and EMA, that authentication has transitioned from being a best-practice to a mandatory requirement.”

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

Blockchain timestamping offers a tamper-proof record that can support inventorship timelines in court.

“As discussed, these examples show that blockchain timestamping offers a tamper-proof record that can support inventorship timelines in court.”

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

Life-cycle analyses demonstrate that correcting just one misidentified, high-throughput screen can offset the CO2 emissions of numerous routine STR runs.

“Environmentally, life-cycle analyses demonstrate that correcting just one misidentified, high-throughput screen can offset the CO2 emissions of numerous routine STR runs.”

May combine two claims.

Decades of use in forensics, clinical diagnostics and cell line repositories have validated STR profiling's reliability, reproducibility and ability to detect even low-level cross-contamination, making it a uniquely practical and universally accepted first-line test for cell authentication.

“Decades of use in forensics, clinical diagnostics and cell line repositories have validated its reliability, reproducibility and ability to detect even low-level cross-contamination, making it a uniquely practical and universally accepted first-line test for cell authentication.”

Probably not a substantial claim: may not pass S3 (load-bearing).

In 2023, the European Medicines Agency (EMA) shared their perspective on the use of AI and ML in aiding the development, assessment, and monitoring of medicinal products in their "Reflection paper on the use of AI in the medicinal product lifecycle".

“Similarly, in 2023 the European Medicines Agency (EMA) shared their perspective on the use of AI and ML in aiding the development, assessment, and monitoring of medicinal products in their “Reflection paper on the use of AI in the medicinal product lifecycle” [160].”

• cites [160] EMA (European Medicines Agency) (2025, August 09). Reflection Paper on the Use of Artificial Intelligence (AI) in the Medicinal Product Lifecycle. Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-reflection-paper-use-artificial-intelligence-ai-medicinal-product-lifecycle_en.pdf.Not checked yet

  Not checked in the free run.

May combine two claims.

Authentication procedures that help prevent failed animal studies indirectly reduce carbon emissions in vivariums and align with the 3Rs.

“Additionally, authentication procedures that help prevent failed animal studies indirectly reduce carbon emissions in vivariums and align with the 3Rs (Replacement, Reduction, Refinement) in animal ethics, as proposed by William M. S. Russell and Rex L. Burch in 1959 [151].”

• cites [151] Russell, W.M.S., and Burch, R.L. (1959). The Principles of Humane Experimental Technique, Universities Federation for Animal Welfare.Not checked yet

  Not checked in the free run.

Probably not a substantial claim: may not pass S3 (load-bearing).

Artificially engineered cell lines derived from BRCA1 mutations can in principle be subject to patent protection.

“However, artificially engineered cell lines derived from BRCA1 mutations can in principle be subject to patent protection.”

May combine two claims.

STR profiling is still considered the gold standard because its highly polymorphic loci provide unmatched discriminatory power, its protocols and allele-calling rules are globally standardized and backed by extensive reference databases, the technique is rapid, inexpensive and requires only minimal DNA.

“However, STR profiling is still considered the gold standard because its highly polymorphic loci provide unmatched discriminatory power, its protocols and allele-calling rules are globally standardized and backed by extensive reference databases, the technique is rapid, inexpensive and requires only minimal DNA.”

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

Economic analyses show that every €1 invested in authentication leads to approximately €6 in savings from preventing downstream costs.

“Economic analyses show that every €1 invested in authentication leads to approximately €6 in savings from preventing downstream costs.”